Controversial young blood transfusions startup is trying to resume operations again

A controversial startup that buys blood plasma from young people and pumps it into the veins of older people is talking with the U.S. Food and Drug Administration about resuming operations, the company now says online. The company, which was founded by a Stanford Medical School graduate, this week told a potential customer that it was currently operating in two cities‚ San Francisco and Tampa, Florida, according to a reporter at Business Insider who viewed the email and first reported on the company's…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news